Paulo was Chief Medical Officer at Xaira Therapeutics, and Chief Scientific and Clinical Development Advisor at STALICLA. Paulo Fontoura joined Roche in 2026.
Paulo Fontoura is currently
Create your alert
to follow the career of Paulo Fontoura.
Paulo Fontoura has a Doctor of Medicine in Medicine from New University of Lisbon in 2007 and a Program in Leadership Development from Harvard Business School - Executive Education in 2015.
They have also studied at Harvard Business School - Executive Education :
Find more alumni from Harvard Business School - Executive Education
Do you need to know more about Paulo Fontoura? More results.
Report an error
Update the org chart details of Paulo Fontoura.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.